These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3509458)

  • 1. Cefoperazone for infections in cancer patients.
    Bodey P; Rolston K; Hsi Ho D
    Chemioterapia; 1987 Jun; 6(2 Suppl):400-2. PubMed ID: 3509458
    [No Abstract]   [Full Text] [Related]  

  • 2. Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
    Menichetti F; Bucaneve G; Patoia L; Guerciolini R; Minotti V; Pauluzzi S; Del Favero A
    Chemioterapia; 1987 Jun; 6(2 Suppl):403-5. PubMed ID: 3334584
    [No Abstract]   [Full Text] [Related]  

  • 3. Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporins.
    Rolston KV; Jones PG; Fainstein V; Khardori NM; Anaissie EJ; Steelhammer L; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):139-45. PubMed ID: 2060514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.
    Watanabe T; Kazuno Y; Hirano F; Inouye S; Nishino T
    Drugs Exp Clin Res; 1985; 11(11):781-6. PubMed ID: 3841789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam in the treatment of soft tissue infections including diabetic foot infections.
    Torres A; Ramírez-Ronda CH
    Bol Asoc Med P R; 1985 May; 77(5):191-4. PubMed ID: 3860207
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of cephalosporins in hospital practice].
    Petite J
    Schweiz Rundsch Med Prax; 1985 Aug; 74(34):882-4. PubMed ID: 3940160
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotic therapy in patients with post-traumatic osteitis.
    Ketterl R; Beckurts T; Stübinger B; Claudi B
    Chemioterapia; 1987 Jun; 6(2 Suppl):436-7. PubMed ID: 3509468
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cefoperazone.
    Liu YK; Zhang JD; Gu JW; Zhang MF; Jiang H; Wang F; Dai ZY
    Chin Med J (Engl); 1986 Nov; 99(11):893-8. PubMed ID: 3107927
    [No Abstract]   [Full Text] [Related]  

  • 10. Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumonia.
    Mangi RJ; Peccerillo KM; Ryan J; Berenson C; Greco T; Thornton G; Andriole VT
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):441-7. PubMed ID: 1643821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cefoperazone in the treatment of bacterial infections in patients with hematological diseases.
    Ichimaru M; Takatsuki K; Niho Y; Sawae Y
    Clin Ther; 1984; 7(1):60-8. PubMed ID: 6518464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of gram-negative bacillary septicemia with cefoperazone.
    Lagast H; Meunier-Carpentier F; Klastersky J
    Eur J Clin Microbiol; 1983 Dec; 2(6):554-8. PubMed ID: 6667681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immediate Gram staining of the bile in operations for gallstones].
    van der Sar P; van der Heyde MN
    Ned Tijdschr Geneeskd; 1984 Jun; 128(26):1222-4. PubMed ID: 6379473
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter clinical trials of cefoperazone in Japan.
    Saito A; Ueda Y
    Clin Ther; 1984; 7(1):49-59. PubMed ID: 6394129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefoperazone. Experience in medico-surgical infections].
    López H; Marcenac FM; Fernández AJ; Lasala MB; Lasala FG
    Rev Clin Esp; 1983 Oct; 171(2):99-101. PubMed ID: 6658100
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacterial infective etiology in 1979 and 1980].
    Salvetti ME; Moretti M
    Ann Ist Super Sanita; 1982; 18(3):463-5. PubMed ID: 7187831
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cefoperazone: microbiological, kinetic and clinical studies].
    Di Nola F; Soranzo ML; Capra E; Eandi M; Salassa B; Arione R; Cimino T; Grosa M; Chiavarino M; Bramato C
    Minerva Med; 1985 Oct; 76(39):1795-801. PubMed ID: 4047462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefoperazone (Medocef*) in the modern therapy of severe bacterial infections].
    Fomina IP; Smirnova LB
    Antibiot Khimioter; 2001; 46(10):35-41. PubMed ID: 11881192
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microbial analysis of clinical material taken from patients at the Oncology Center, Maria Skłodowkda-Curie Institute in Warsaw in 1997].
    Fuksiewicz A; Połowniak-Pracka H; Ochman E; Podsiadło B
    Med Dosw Mikrobiol; 1999; 51(3-4):363-74. PubMed ID: 10803266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.